DelSiTech is a drug delivery and drug development company based in Turku, Finland.
Its technology has been applied to controlled release of small molecules, biopharmaceuticals, and viral vectors. DelSiTech works with partners from early feasibility testing to clinical proof of concept, and its technology can be licensed to industry partners.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The technology has been applied to controlled release of small molecules, biopharmaceuticals, and viral vectors, with a focus on parenteral and local administration.
Source: LinkedIn company description · Retrieved October 13, 2026
DelSiTech is developing its own in-house supergeneric drug products for unmet medical and market needs.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Open the published source list.RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 3, 2026. Directory positions use company-contact counts from separate saved list snapshots dated August 31, 2026, September 16, 2026, September 18, 2026, September 19, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.